- Essential chemotherapy drugs, including ifosfamide, cisplatin, and carboplatin, are facing severe shortages across the U.S.
- The scarcity is due to shipping delays, manufacturing problems, and some companies discontinuing medications, according to the FDA.
- Doctors are being forced to make difficult decisions, such as rationing available doses and prioritizing younger patients with a higher chance of recovery.
- Some medical practices are adapting by spacing out treatment times or scheduling consecutive appointments to ensure no medication is wasted.
- The Department of Health and Human Services is actively working with manufacturers and stakeholders to address shortages and explore solutions such as temporary importation.
IN FULL
